Skip to main content

NXP Accelerates the Transformation to Software-Defined Vehicles (SDV) with Agreement to Acquire TTTech Auto

NXP announced today that it has entered into a definitive agreement to acquire TTTech Auto.NXP strengthens its automotive business with a leading software solution provider specialized in the systems, safety and security required for SDVs.NXP strengthens its automotive business with a leading software solution provider specialized in the systems, safety and security required for SDVs TTTech Auto complements and accelerates the NXP CoreRide platform, enabling automakers to reduce complexity, maximize system performance and shorten time to market The acquisition is the next milestone in NXP’s strategy to be the leader in intelligent edge systems in automotive and Industrial IoTEINDHOVEN, The Netherlands, Jan. 07, 2025 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI), the worldwide leader in automotive processing...

Continue reading

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (“THE CODE”). THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. For immediate release 7 January 2025 Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA NEW YORK and VIENNA, Austria, Jan. 07, 2025 (GLOBE NEWSWIRE) — Further to the announcement on 2 January 2025 (the “2.4 Announcement”), the Boards of Poolbeg and HOOKIPA are pleased to confirm that significant HOOKIPA...

Continue reading

Gilat Completes Acquisition of Stellar Blu Solutions LLC

Acquisition Supercharges Gilat’s IFC Growth, Establishing a Global Leader in Aviation and High-End Mobility for ESA Applications Expected to Add $120-150 million in 2025 Annual Revenues PETAH TIKVA, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a global leader in satellite networking technology, solutions, and services, today announced that it has successfully closed the acquisition of Stellar Blu Solutions LLC (“Stellar Blu”), a leading US-based provider of next-generation SATCOM terminal solutions. Gilat expects its annual revenues from Stellar Blu to range between $120 and $150 million in 2025, based on Stellar Blu’s robust backlog. In addition, the acquisition is expected to be accretive on non-GAAP results for 2025. Furthermore, the Company estimates that once Stellar Blu...

Continue reading

Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 Jan 2025 – 7AM CET Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil Fagron, the leading global player in pharmaceutical compounding is pleased to announce the signing of two strategic acquisitions: CareFirst Specialty Pharmacy in North America and Injeplast in Brazil. These acquisitions underscore Fagron’s commitment to expanding across our key markets whilst adhering to our disciplined acquisition strategy. The combined enterprise value of these two acquisitions is c.€30m and are fully financed through Fagron’s own resources and remain subject to customary clearances. Both businesses operate with an EBITDA margin slightly above Fagron’s existing group margin. CareFirst Specialty Pharmacy, based in...

Continue reading

BE Resources Announces Termination of Proposed Business Combination With Bio Graphene Solutions

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) —  BE Resources Inc. (the “Company” or “BE Resources”) (TSXV: BER.H) announces its letter of intent (the “LOI”) for a proposed transaction with Bio Graphene Solutions Inc., as announced on August 17, 2020, has been terminated. The LOI was previously extended several times, most recently until December 31, 2024, however the Company determined to not extend the LOI past December 31, 2024. The Company will continue to seek to reposition its business and notwithstanding the termination of the LOI, may re-engage with Bio Graphene or seek alternative transactions to optimize value for shareholders. Trading in the common shares of the Company was halted as of August 18, 2020, in connection with the execution of the LOI. The Company will seek to resume trading as soon as possible. Carmelo...

Continue reading

Core Specialty to Acquire London Aviation Underwriters and Form Aviation & Aerospace Division

London Aviation Underwriters to operate as a separately managed Division of Core Specialty as its 18th specialty business unit Core Specialty to retain the London Aviation Underwriters (LAU) brand and management team Jeff Sutton to become President of the new Aviation & Aerospace Division LAU produced $56mm of GAAP gross premiums written in 2023 Transaction expected to close in early 2025CINCINNATI, Jan. 06, 2025 (GLOBE NEWSWIRE) — Core Specialty Insurance Holdings, Inc. and its subsidiaries (“Core Specialty” or the “Company”) and London Aviation Underwriters, Inc. (“LAU”) announced today the signing of a purchase agreement whereby Core Specialty will acquire LAU in a stock and cash transaction. LAU will bring decades of aviation and aerospace underwriting and claims experience and expertise in-house. Upon closing, LAU...

Continue reading

Forsys Reaches Agreement to Purchase Farm Namibplaas Portion-1 on Exclusive Prospecting Licence (EPL-3638)

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) is pleased to announce that its wholly-owned subsidiary Valencia Uranium (Pty) (“Valencia Uranium”) has finalised an agreement with Namibplaas Guestfarm and Tours (Proprietory) Limited (the “Farm Owner”) for the purchase of Portion-1 of farm Namibplaas No. 93 (the “Property”), at the Company’s Norasa Uranium project (“Norasa1”). The Property hosts the Namibplaas uranium deposit (“Namibplaas”), under Exclusive Prospecting Licence (EPL-3638)   The purchase of this Property is the final outcome of lengthy negotiations for the economic terms for access rights with the previous farm owner. EPL-3638 covers a total surface area of 1,266 ha; with approximately 93 % (1,179 ha) located on the Property, which measures...

Continue reading

GCC Closes Strategic Aggregates Acquisitions

CHIHUAHUA, Mexico, Jan. 06, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, today announced the acquisition of three pure-play aggregates operations in Texas, for approximately US$100 million, subject to potential customary post-closing adjustments. These assets add more than 4 million tons of annual production capacity and more than 50 years of proven, high-quality reserves to GCC’s portfolio. The acquisitions strengthen GCC’s presence in the Amarillo, Midland-Odessa, Dallas-Fort Worth, and San Antonio, Texas, markets, key regions for growth and infrastructure development. “These acquisitions mark an important milestone in our strategy to expand into key growth markets,” said Enrique Escalante, GCC’s CEO. “This move not only expands our product...

Continue reading

Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) —  Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion. Inari, which was founded in 2011, will bring a leading peripheral vascular position in the fast-growing segment of venous thromboembolism (VTE) to Stryker. Inari’s innovative product portfolio is highly complementary to Stryker’s Neurovascular business and includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Each year, VTE impacts up to 900,000 lives in the United States,...

Continue reading

Nobel Resources Signs Option Agreements to Acquire 100% Interest in Chilean Copper Portfolio in Antofagasta Region, Chile

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX – V: NBLC) (the “Company” or “Nobel”) is pleased to announce it has entered into binding agreements pursuant to which it can acquire a 100% interest in four separate copper projects (collectively, the “Projects”), namely Cuprita, Janett, Pampa Austral and Anais (the “Transaction”). The Projects are being acquired by Nobel’s wholly owned Chilean subsidiary, Mantos Grandes Resources Chile SpA (“Mantos”). Mantos is acquiring the Cuprita Project claims pursuant to an option agreement dated January 3, 2025 between Mantos and a group of private Chilean companies listed below. The Cuprita Project is the most advanced Project being acquired pursuant the Transaction and will be the Company’s principal asset following the closing of the Transaction. Cuprita is a highly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.